GSH is generated by de novo synthesis in a process mediated by two ATP-dependent ligases (glutamate-cysteine ligase and glutathione synthase), as well as by the regeneration of GSH from GSSG, a process catalyzed by glutathione disulfide reductase
They reflect the actual structure of the platform and represent a meaningful departure from competitors that bury ongoing charges in fine print
Tirzepatide targets two hormones to control appetite and blood glucose, while retatrutide targets three, potentially helping with fat burning
In February 2025, Gan & Lee Pharmaceuticals (hereafter referred to as "Gan & Lee," stock code: 603087.SH) unveiled that the first participant was successfully dosed in a large-scale Phase 3 clinical trial (OPTIMUM-2) of Bofanglutide, a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) independently, in Chinese participant with type 2 diabetes mellitus (T2DM)
Martens MD et al
Single vials and bulk quantities are available for ongoing study protocols